Aqua Products, Inc. v. Matal: Petitioners Bear the Burden of Establishing the Unpatentability of Amended Claims in IPR Proceedings
October 10, 2017
Upending the current motion-to-amend practice before the Patent Trial and Appeal Board (“the PTAB”), a deeply fractured en banc Federal Circuit in Aqua Products., Inc. v. Matal, No. 2015-1177 (Fed. Cir. Oct. 4, 2017), has shifted the burden of persuasion onto petitioners to establish the unpatentability of amended claims proffered by patent owners during inter partes review (“IPR”) proceedings. Under the PTAB’s current practice, patent owners have faced great difficulty in successfully amending claims in IPR proceedings. That may change in light of the Federal Circuit’s ruling in Aqua Products.
The Federal Circuit’s opinions leave open the possibility that the Patent and Trademark Office (“the PTO”) may attempt to promulgate regulations re-imposing the burden of persuasion on patent owners. Five of the court’s members, however, indicated that any such regulation would be foreclosed by the America Invents Act (“the AIA”). Whether patent owners would now seek to take greater advantage of the opportunity to amend may also depend on other factors, such as the PTAB’s overall receptivity to motions to amend and the amendment’s implications for the recovery of damages in any parallel litigation.
In 2003, Zodiac Pool Systems, Inc. (“Zodiac”) filed an IPR petition challenging certain claims of U.S. Patent No. 8,273,183, assigned to Aqua Products, Inc. (“Aqua Products”). Following institution, Aqua Products proposed substitute claims. In its final written decision, the PTAB held both the challenged and proposed substitute claims unpatentable and denied Aqua Products’ motion to amend. The Board concluded that Aqua Products had not carried the ultimate burden of persuasion of showing patentability with respect to the proposed substitute claims. Aqua Products appealed the PTAB’s denial of the motion to amend.
On appeal, a Federal Circuit panel upheld the PTAB’s assignment to the patent owner of the burden of persuasion on the patentability of proposed substitute claims, and concluded that the PTAB did not err in holding the proposed substitute claims unpatentable. Aqua Products sought an en banc rehearing to challenge the burden-of-persuasion assignment regarding proposed substitute claims as impermissible under 35 U.S.C. § 316(e). On August 12, 2016, the Federal Circuit vacated the panel’s decision and granted en banc review.
The En Banc Court’s Opinions
In a 6-5 vote, the en banc Federal Circuit vacated the PTAB’s final written decision denying Aqua Products’ motion to amend, and remanded the case for the PTAB to issue a final decision assessing the patentability of the proposed substitute claims “without placing the burden of persuasion on the patent owner.”
The question of the appropriate burden of proof deeply divided the Federal Circuit, resulting in five different opinions, none of which garnered enough votes to serve as the opinion of the court. The members of the en banc court disagreed whether the applicable statute—the AIA—clearly addressed the issue, and whether the PTO’s interpretation of the statute was entitled to deference.
The lead opinion, authored by Judge O’Malley, commanded five votes of the en banc court, but fell one vote short of the majority.
The lead opinion acknowledged, however, that the remaining six members of the en banc Federal Circuit—hence, the majority of the court—believed the statute to be ambiguous on this point.
The two additional votes to reverse the PTAB, and to hold that the burden of persuasion with respect to the patentability of amended claims lies with the petitioner, were supplied by Judges Reyna and Dyk. In a separate opinion, authored by Judge Reyna, they concluded that the PTO “does not possess the statutory authority to issue through adjudication a substantive rule that creates and allocates a burden of persuasion,” as opposed to through formal notice-and-comment rulemaking.
The remaining four judges of the en banc court dissented. In the principal dissent, Judge Taranto would have held that the AIA is ambiguous with respect to who bears the burden of persuasion on the amended claims, and that “a PTO regulation assigns the burden of persuasion to the patent owner.”
Because the participating en banc judges had different views, both as to the judgment and the underlying rationale, the Aqua Products court’s holding was fairly narrow. The Federal Circuit held that, at least in the absence of any future rulemaking by the PTO, the burden of persuasion with respect to the patentability of amended claims in IPR proceedings resides with the petitioner. The members of the en banc court disagreed, however, whether that outcome was mandated by statute (as five judges would have held) or was the result of the PTO not having gone through a proper notice-and-comment process (as two other judges concluded). As a result, the Federal Circuit’s opinions leave open the possibility that the PTO may attempt to promulgate regulations re-imposing the burden of persuasion on the patent owner.
It remains to be seen, however, whether patent owners will seek to take greater advantage of the opportunity to amend, and how Aqua Products will affect pending AIA trials involving motions to amend. While the shift in the burden may make it easier for patent owners to move to amend claims, the PTAB may still reject the amended claims if it concludes that they are not distinguished from the prior art. In addition, patent owners seeking to amend their claims should be mindful of the implications of such amendments for any parallel infringement litigation. The doctrine of intervening rights may potentially prevent patent owners from recovering past damages in litigation if the claims of the patent-in-suit are amended.
Finally, the different Aqua Products opinions illuminate the different approaches that members of the Federal Circuit apply to questions of statutory interpretation and administrative deference. As the opinions illustrate, some members of the court are more willing to defer to the PTO’s interpretation, whereas other members are more inclined to construe the governing statute themselves. Federal Circuit judges also have divergent views on the degree of formality required of the PTO’s rulemaking before the agency receives judicial deference.
Does Your Research Compliance Need a Refresh? China’s Highest Court Sends a Warning to Life Sciences Companies
October 9, 2017